Epidermal growth factor receptor inhibitor-related folliculitis.
Tangri
Navdeep
N
Al Hammadi
Anwar
A
Gerstein
William
W
D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy; D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D000069347:Erlotinib Hydrochloride; D005145:Face / Q000473:pathology; D005499:Folliculitis / Q000139:chemically induced / Q000175:diagnosis* / Q000473:pathology; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D009333:Neck / Q000473:pathology; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D011799:Quinazolines / Q000008:administration & dosage / Q000009:adverse effects*
D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D066246:ErbB Receptors